HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

BACKGROUND: HAGE protein is a known immunogenic cancer-specific antigen. METHODS: The biological, prognostic and predictive values of HAGE expression was studied using immunohistochemistry in three cohorts of patients with BC (n=2147): early primary (EP-BC; n=1676); primary oestrogen receptor-negati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abdel-Fatah, T M A, McArdle, S E B, Johnson, C, Moseley, P M, Ball, G R, Pockley, A G, Ellis, I O, Rees, R C, Chan, S Y T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4021517/
https://ncbi.nlm.nih.gov/pubmed/24755885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados